criteria for informing patients about voluntary drug recalls?

PLEASE NOTE:   Posts made to this forum should not be considered as the expressed opinions of, nor should be considered endorsed by, the Medication Safety Officer’s Society (MSOS) or the Institute for Safe Medication Practices (ISMP). 

Make sure your email is up-to-date
In order to continue to receive updates from MSOS, as well as forum posts and other valuable information as a member of MSOS, please be sure to update your email address with us, whenever it changes. If you need assistance doing so, please send an email to jrufo@ismp.org. 

3 posts / 0 new
Log in or register to post comments
Last post
Fri, 06/29/2018 - 16:21
#1
Julie Kindsfater
Julie Kindsfater's picture
Offline
Last seen: 4 weeks 1 day ago
Joined: 11/04/2011 - 10:15
criteria for informing patients about voluntary drug recalls?

I received a question from supply chain whether communication needs to go out to patients who received Apotex fluticasone given the voluntary recall. This is mostly coming from our retail rx, but I am curious whether anyone has criteria for sending communication out to patients. Thanks!

Top